Ready to Drink WHO Oral Rehydration Salts (Apple & Orange Flavour) from the makers of ORSL

Composition: Ready to drink Solution. Each 200 ml contains 2.7 g glucose; Potassium Chloride 0.30 g; Sodium Chloride 0.52 g; Sodium Citrate 0.58 g.

Therapeutic Indication: For Oral rehydration in diarrhea and various other etiologies where there is loss of water and electrolytes.

Dosage & Administration: The amount of ORS needed for rehydration is calculated based on the child’s weight. The amount of solution required also depends on the child’s dehydration status. Children with more marked signs of dehydration or who continue to pass frequent watery stools will require more solution than those with less marked signs or who are not passing frequent stools. [1, [i]] If a child requires more than the estimated amount of ORS solution, and there are no signs of overhydration, give more. The approximate amount of ORS solution to give in the first 4 hours. Below 4 months less than 5 kg: 200–400 mL 4–11 months / 5–7.9 kg: 400–600 mL 12–23 months / 8–10.9 kg: 600–800 mL; To 4 years / 11–15.9 kg: 800–1,200 mL; To 14 years / 16–29.9 kg: 1,200–2,200 mL; 15 years or older / 30 kg or more: 2,200–4,000 mL. In adults and children ORS can be given in amounts necessary to satisfy thirst. As with infants, solids should be avoided during the first day but may gradually resume as necessary during day 2. It is extremely difficult to over-hydrate by mouth, thus when there is normal renal function, it is better to give more ORS than less.

Contraindications: Patients with severe diarrhea where parenteral fluid therapy is required, such as severe dehydration or intractable vomiting. Hypersensitivity to glucose, potassium chloride, sodium chloride and sodium citrate or to any of the ingredients. Patients with renal failure manifesting as oliguria or anuria, intestinal obstruction, paralytic ileus, severe and persistent diarrhea and vomiting, inability to drink or retain oral fluids.

Warnings & Precautions: Caution required in patients with renal or adrenal insufficiency acute dehydration, or muscle cramps as well as patients receiving potassium-sparing diuretics, angiotensin-converting enzyme inhibitors, and potassium-containing or other potassium-sparing drugs. In patients with cardiac failure, hypertension, peripheral edema and pulmonary edema, eclampsia/pre-eclampsia, or aldosteronism. Should not be mixed or given with other oral electrolyte solutions. Salt or sugar should not be added to the ORS. Infants under the age of 2 years with severe diarrhoea/vomiting should be seen by a doctor as soon as possible.

Adverse reactions: Vomiting. If vomiting occurs, administration should be halted for 10 minutes, then resumed in smaller, more frequent, amounts. The risk of hypernatremia or overhydration after administration of oral rehydration solutions is low in patients with normal renal function.

Use in Special Populations: ORS can be administered to pregnant women and breastfeeding mother. Medical supervision is recommended for use during pregnancy and lactation.

Overdose: In oral electrolyte replacement therapy, toxicity is rare in previously healthy people. In subjects with renal impairment, hypernatremia and hyperkalemia might occur.

For complete prescribing information please contact marketer at JNTL Consumer Health (India) Pvt. Ltd. Office No.16, Admin Block, Ground Floor, Lal Bahadur Shastri (L.B.S.) Marg, Mulund, Greater Mumbai, Maharashtra-400080.

Disclaimer: This material represents confidential proprietary information of JNTL. Not to be stored, disseminated or disclosed by the viewer. For the use of registered medical practitioners only.

Information generated date: 30 May 2025